Stay ahead of regulatory changes with this focused course on the Proposed Rule for the Medicare Drug Price Negotiation Program. Built from the Inflation Reduction Act of 2022, this training covers new Medicare drug negotiation policies, compliance expectations for manufacturers, negotiation processes, updates to the Medicare Prescription Drug Benefit, and public participation opportunities. Learn how these changes affect pricing, reporting, and your organization’s obligations in the evolving healthcare landscape.
In this course you will learn the following:
* Understand the goals and structure of the proposed Medicare Drug Price Negotiation Program.
* Identify the main provisions and requirements for manufacturers, CMS, and stakeholders.
* Recognize the process for negotiation, renegotiation, and compliance.
* Analyze the impact of the proposed rule on drug pricing, Medicare beneficiaries, and the pharmaceutical industry.
* Learn how to engage in the public comment process and anticipate potential changes.
